Clinical Trial Update: Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen [Phase 2]

View source ↗

Summary

Pfizer conducted a Phase 2 trial of capravirine (AG1549) in combination with Viracept and two NRTIs in HIV-infected patients who failed an initial NNRTI-contain…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Capravirine (capravirine)
• Viracept (Nelfinavir)

Snippet

Sponsor: Pfizer | Conditions: Human Immunodeficiency Virus | Phase 2 | Status: COMPLETED